Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer
Peter H. O’Donnell, Matthew I. Milowsky, Daniel Peter Petrylak, Christopher J. Hoimes, Thomas W. Flaig, Nataliya Mar and 19 more
- Rank
- 41 of 529
- Percentile
- top 7.8%
- Where
- Journal of Clinical Oncology, 2023
- Citations
- 197
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.